A Randomized Phase III Trial of Concurrent Chemoradiotherapy Followed by Durvalumab Consolidation, With or Without Induction Chemo-Immunotherapy, in Patients With Unresectable Locally Advanced Non–Small Cell Lung Cancer: JCOG2510 (PRIME-CRT)

Clinical Lung Cancer · Elsevier

Аннотация

Publication date: November 2026 Source: Clinical Lung Cancer, Volume 27, Issue 9 Author(s): Kota Kawabata, Ken Masuda, Keita Miura, Yu Saida, Ryo Ko, Hiroaki Akamatsu, Hidehito Horinouchi, Takahito Chiba, Kae Okuma, Hideyuki Harada, Yoshimasa Shiraishi, Yasushi Goto, Shogo Nomura, Noriko Mitome, Haruhiko Fukuda, Isamu Okamoto, Hirotsugu Kenmotsu, Lung Cancer Study Group of the Japan Clinical Oncology Group

Читать у издателя →

Похожие статьи